Category Archives: News

BTS Research Appoints VP of Toxicology to Oversee Sponsors’ Preclinical Tox Programs

By | News | No Comments

SAN DIEGO–(BUSINESS WIRE)–BTS Research announced today that they have appointed Ian Dean as their VP of Toxicology. Ian has over 27 years in the nonclinical contract research industry, with experience across UK, Canada, Asia and the US.

In addition, Ian had various responsibilities in previous CRO’s such as Huntingdon Research Centre (now Envigo), Inveresk Research International (now Charles River), ITR, Southern Research Institute, LAB (now CiToxLab) and Primetrics – Singapore. In addition, Ian has spent 10 years as an independent regulatory consultant and was an Expert External Reviewer for Health Canada’s New Drug Submissions. Ian has extensive preclinical and clinical expertise spanning protocol design, study oversight, regulatory gap analysis, audit of nonclinical and clinical bioanalysis facilities, and preparing regulatory documentation. He is a Diplomate of the Institute of Biology in Toxicology (DIBT) and a Diplomate of the American Board of Toxicology (DABT; 1995-2015).

Ian and a group of Senior Scientists and Study Directors that have been hired over the last six months at BTS are now able to cover the increasing demand for study and program oversight.

“BTS Research is now much more prepared to take on multiple programs and maintain the quality and speed expected by its clients,” BTS President & CEO Sami Abunadi commented. “We are pleased to have Ian join us along with the fantastic new and talented in vitroand in vivo scientists who have proven track record to meet this increasing demand. With the recent expansions in the lab and vivarium space, we had to increase our scientific base to be able to execute with speed and quality,” Mr. Abunadi added.

About BTS Research

BTS is a San Diego based Contract Research Organization (“CRO”) that delivers GLP and Non-GLP biological services to large and small clients in pharmaceutical/biopharmaceutical, biotech, academic research and medical device organizations in the areas of Inflammation, Metabolic Disease, Cancer, Stem Cell and Medical Devices since 2001. BTS Research is a recognized leader in providing global preclinical solutions in all regulated species from early discovery to IND enabling studies.


BTS Research
Antonio Civitarese PhD, MBA
Associate Director of Marketing & Alliance Management
(858) 605-5882 X 317

BIO-QUANT announces the expansion of its research animal diagnostic services to cover all nine species

By | News | No Comments

SAN DIEGO, CA, September, 2008 –Bio-Quant Inc (“Bio-Quant”) the largest biotech Contract Research Organization (CRO) in San Diego, announced today the expansion of its animal diagnostic services division to cover all nine species used in research.
Dr. Bassam Damaj, Chief Executive Officer of Bio-Quant, said, “Animal welfare is of great importance, and Bio-Quant is very pleased to announce the expansion of its Research Animal Diagnostic Services. Bio-Quant is the only local facility providing this high quality service to the San Diego community, and we will continue to grow our capabilities in this area to support our client’s needs. This marks the completion of our planned expansion program that we have been implementing over the last couple of years”
He added, “Our laboratory covers comprehensive clinical chemistry, hematology, coagulation, blood gas analysis, urine analysis for all nine species. The advanced equipments used at Bio-Quant allows the analysis of full CBC with only 15uL of blood as opposed to the 100uL required by most laboratories allowing researchers to run multiple CBCs during their experimental studies without affecting the health status of the animals.”
Other specialty services are also provided worldwide by Bio-Quant such as Elisa, FACS analysis, protein electrophoresis, and gel electrophoresis as well as in vitro cellular functional assays.
About Bio-Quant, Inc.
Bio-Quant, Inc. is a profitable revenue-generating biotechnology pre-clinical contract research organization specializing in in vitro and in vivo pharmacology, PK and toxicology to support non-GLP pre-IND enabling studies in addition to vivarium housing services. The company is based in San Diego, California with 20,000 sq ft office and laboratory facilities. The company specializes in pre-clinical work in the areas of Inflammation, Oncology, and Immunology, PK and toxicology services.
More information is available at :